AAAAAA
Results:
1-19
|
Results: 19
Authors:
Gorschluter, M
Ziske, C
Glasmacher, A
Schmidt-Wolf, IGH
Citation: M. Gorschluter et al., Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma, CLIN CANC R, 7(8), 2001, pp. 2195-2204
Authors:
Gorschluter, M
Glasmacher, A
Hahn, C
Schakowski, F
Ziske, C
Molitor, E
Marklein, G
Sauerbruch, T
Schmidt-Wolf, IGH
Citation: M. Gorschluter et al., Clostridium difficile infection in patients with neutropenia, CLIN INF D, 33(6), 2001, pp. 786-791
Authors:
von Lilienfeld-Toal, M
Ebert, O
Theuerkauf, I
Glasmacher, A
Schmidt-Wolf, IGH
Citation: M. Von Lilienfeld-toal et al., Small bowel obstruction in acute myelogenous leukemia: stenosis or paralysis?, ANN HEMATOL, 80(10), 2001, pp. 611-613
Authors:
Gorschluter, M
Glasmacher, A
Hahn, C
Leutner, C
Marklein, G
Remig, J
Schmidt-Wolf, IGH
Sauerbruch, T
Citation: M. Gorschluter et al., Severe abdominal infections in neutropenic patients, CANCER INV, 19(7), 2001, pp. 669-677
Authors:
Marten, A
Renoth, S
von Lilienfeld-Toal, M
Buttgereit, P
Schakowski, F
Glasmacher, A
Sauerbruch, T
Schmidt-Wolf, IGH
Citation: A. Marten et al., Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells, HAEMATOLOG, 86(10), 2001, pp. 1029-1037
Authors:
Pels, H
Glasmacher, A
Schmidt-Wolf, IGH
Schlegel, U
Citation: H. Pels et al., Therapy of primary CNS lymphoma, AKT NEUROL, 28(4), 2001, pp. 189-194
Authors:
Engelhart, S
Glasmacher, A
Kaufmann, F
Exner, M
Citation: S. Engelhart et al., Protecting vulnerable groups in the home: The interface between institutions and the domestic setting, J INFECTION, 43(1), 2001, pp. 57-60
Authors:
Schlegel, U
Pels, H
Glasmacher, A
Kleinschmidt, R
Schmidt-Wolf, I
Helmstaedter, C
Fliessbach, K
Deckert, M
Van Roost, D
Fimmers, R
Bode, U
Klockgether, T
Citation: U. Schlegel et al., Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study, J NE NE PSY, 71(1), 2001, pp. 118-122
Authors:
Schlenk, RF
Frohling, S
Del Valle, F
Hartmann, F
Glasmacher, A
Fischer, JT
Grimminger, W
Weber, C
Weber, W
Gunzer, U
Gotze, K
Waterhouse, C
Benner, A
Dohner, K
Haas, R
Ho, AD
Dohner, H
Citation: Rf. Schlenk et al., Stratification of postremission therapy in patients with acute myeloid leukemia <= 60 years according to the karyotype: Results of the German multicenter treatment trials AML HD93 and AML HD98-A, HEMAT BLOOD, 40, 2001, pp. 470-476
Authors:
Frohling, S
Schlenk, RF
Del Valle, F
Hartmann, F
Glasmacher, A
Fischer, JT
Grimminger, W
Weber, C
Weber, W
Gunzer, U
Gotze, K
Dohner, K
Haas, R
Ho, AD
Dohner, H
Citation: S. Frohling et al., Chemotherapy and all-trans retinoic acid in patients > 60 years with acutemyeloid leukemia: First results of the multicenter treatment trial AML HD98-B, HEMAT BLOOD, 40, 2001, pp. 604-608
Authors:
Leutner, CC
Gieseke, J
Lutterbey, G
Kuhl, CK
Glasmacher, A
Wardelmann, E
Theisen, A
Schild, HH
Citation: Cc. Leutner et al., MR imaging of pneumonia in immunocompromised patients: Comparison with helical CT, AM J ROENTG, 175(2), 2000, pp. 391-397
Authors:
Pels, H
Deckert-Schluter, M
Glasmacher, A
Kleinschmidt, R
Oehring, R
Fischer, HP
Bode, U
Schlegel, U
Citation: H. Pels et al., Primary central nervous system lymphoma: A clinicopathological study of 28cases, HEMATOL ONC, 18(1), 2000, pp. 21-32
Authors:
Scheffold, C
Schottker, B
Lefterova, P
Csipai, M
Glasmacher, A
Huhn, D
Neubauer, A
Schmidt-Wolf, IGH
Citation: C. Scheffold et al., Increased sensitivity of myeloid leukemia cell lines: Potential of lovastatin as bone-marrow-purging agent, ACT HAEMAT, 104(2-3), 2000, pp. 72-79
Authors:
Steinmetz, HT
Schulz, A
Staib, P
Scheid, C
Glasmacher, A
Neufang, A
Franklin, J
Tesch, H
Diehl, V
Wickramanayake, PD
Citation: Ht. Steinmetz et al., Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML, ANN HEMATOL, 78(9), 1999, pp. 418-425
Authors:
Leutner, C
Gieseke, J
Lutterbey, G
Kuhl, CK
Flacke, S
Glasmacher, A
Theisen, A
Wardelmann, E
Grohe, C
Schild, HH
Citation: C. Leutner et al., MRT versus CT in the diagnosis of pneumonia: evaluation of a T-2-weighted ultrafast turbo-spin-echo sequence (UTSE)., ROFO-F RONT, 170(5), 1999, pp. 449-456
Authors:
Glasmacher, A
Hahn, C
Leutner, C
Molitor, E
Wardelmann, E
Losem, C
Sauerbruch, T
Marklein, G
Schmidt-Wolf, IGH
Citation: A. Glasmacher et al., Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole, MYCOSES, 42(7-8), 1999, pp. 443-451
Authors:
Glasmacher, A
Hahn, C
Molitor, E
Sauerbruch, T
Schmidt-Wolf, IGH
Marklein, G
Citation: A. Glasmacher et al., Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia, MYCOSES, 42(5-6), 1999, pp. 395-402
Authors:
Glasmacher, A
Hahn, C
Molitor, E
Marklein, G
Sauerbruch, T
Schmidt-Wolf, IGH
Citation: A. Glasmacher et al., Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules, MYCOSES, 42(11-12), 1999, pp. 591-600
Authors:
Shlegel, U
Pels, H
Glasmacher, A
Kleinschmidt, R
Bode, U
Citation: U. Shlegel et al., Combined high-dosage polychemotherapy as efficient single therapy of primary cerebral lymphomas, AKT NEUROL, 25(7), 1998, pp. 297-303
Risultati:
1-19
|